Importance Heterogeneous evidence exists for the association between COVID-19 and the
clinical outcomes of patients with mental health disorders. It remains unknown whether …

Individuals diagnosed with schizophrenia or bipolar disorder have a life expectancy 15–20
years shorter than that in the general population. The rate of unnatural deaths, such as …

The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

People with severe mental illness (SMI)–schizophrenia, bipolar disorder and major
depressive disorder–appear at risk for cardiovascular disease (CVD), but a comprehensive …

Psychiatric disorders, and especially severe mental illness, are associated with an
increased risk of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 …

Mental health disorders are a burgeoning global public health challenge, and
disproportionately affect the poor. Low-and middle-income countries (LMICs) bear 80% of …

The diagnosis of mental disorder initially appears relatively straightforward: Patients present
with symptoms or visible signs of illness; health professionals make diagnoses based …

Excess mortality in persons with severe mental disorders (SMD) is a major public health
challenge that warrants action. The number and scope of truly tested interventions in this …

Aims: People with serious mental illness are increasingly turning to popular social media,
including Facebook, Twitter or YouTube, to share their illness experiences or seek advice …

Depression is widely acknowledged to be a heterogeneous entity, and the need to further
characterize the individual patient who has received this diagnosis in order to personalize …